Scientists Develop Ingestible Robot That Delivers Insulin Without The Need For External Needles

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then ...

The robotic drug delivery system includes an implant near the intestines and magnetic capsules that would resupply the implant with medicine. (The Biorobotics Institute, Scuola Superiore Sant’ Anna)

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then travels down their digestive system until it reaches the point where the device is implanted near their small intestine. The device then uses the power of magnets to rotate the capsule into position and then punctures it with a retractable needle and pumps the refill of insulin into a reservoir, reports EndGadget.

One of the most convenient things about this system is that the dispenser charges wirelessly, limiting the number of interventions a doctor needs to maintain the device. Once the capsule is empty, it continues its travel down the digestive system until the user releases it with his stool.

Read more: This Coin-Sized Smart Patch Delivers Insulin as Blood Sugar Increases

The researchers tested their device on three diabetic pigs. They found the system could successfully manage their insulin levels for several hours. In some instances, they found bodily fluids from the pigs would leak into the robot. So as a next step, the team is working on sealing the device better.

Sam Draper
August 20, 2021

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Robot Predicts When You’re Going to Smile

Researchers have created a robot that can predict when a person is going to smile.

Facedrive Launching Pilot Project For Its COVID-19 Contact Tracing Wearable in Partnership with LiUNA

Facedrive, a leading tech developer, announced that its COVID-19 contact tracing wearable solution.

Mendix Named a Leader in Gartner Magic Quadrant for Multiexperience Development Platforms

Mendix has been placed as a Leader for Multiexperience Development Platforms.

NeuroMetrix Restructuring Business After Q2 2019 Results Show Weak Performance of Quell Pain Relief Wearable

Following Q2 2019 financial results, NeuroMetrix has sought help from investors in...
Discover more